7-day dexcom g5 sensor Search Results


periodic rtcgm  (Dexcom Inc)
86
Dexcom Inc periodic rtcgm
Forest plots of randomised controlled trials that compared continuous glucose monitoring vs. blood glucose monitoring for (A) HbA1c (%), (B) time in range (%), (C) time below range (<3.9 mmol/L) (%), (D) time below range (<3.0 mmol/L) (%), (E) time above range (>10 mmol/L) (%), (F) time above range (>13.9 mmol/L) (%) and (G) coefficient of variability. *, Wada, 2020 data for 1F is % TAR (>13.3 mmol/L). CGM, continuous glucose monitoring; isCGM, intermittently scanned CGM; <t>rtCGM,</t> real‐time <t>CGM;</t> <t>BGM,</t> blood glucose monitoring; HbA1c, glycated haemoglobin; TAR, time above range.
Periodic Rtcgm, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/7-day+dexcom+g5+sensor/periodic+rtcgm/pmc12515760-40-15-17
Average 86 stars, based on 1 article reviews
periodic rtcgm - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier
non adjunctive final labeling dexcom g5 mobile system user guide 318technical information  (Dexcom Inc)
86
Dexcom Inc non adjunctive final labeling dexcom g5 mobile system user guide 318technical information
Forest plots of randomised controlled trials that compared continuous glucose monitoring vs. blood glucose monitoring for (A) HbA1c (%), (B) time in range (%), (C) time below range (<3.9 mmol/L) (%), (D) time below range (<3.0 mmol/L) (%), (E) time above range (>10 mmol/L) (%), (F) time above range (>13.9 mmol/L) (%) and (G) coefficient of variability. *, Wada, 2020 data for 1F is % TAR (>13.3 mmol/L). CGM, continuous glucose monitoring; isCGM, intermittently scanned CGM; <t>rtCGM,</t> real‐time <t>CGM;</t> <t>BGM,</t> blood glucose monitoring; HbA1c, glycated haemoglobin; TAR, time above range.
Non Adjunctive Final Labeling Dexcom G5 Mobile System User Guide 318technical Information, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/7-day+dexcom+g5+sensor/296technical+adjunctive+agreement+dexcom+final+g5+guide+information+labeling+mobile+non+system+user/fda_document____cdrh_docs_slash_pdf12_slash_p120005s041c-2835-96-99
Average 86 stars, based on 1 article reviews
non adjunctive final labeling dexcom g5 mobile system user guide 318technical information - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier
ilet bionic pancreas system  (Dexcom Inc)
86
Dexcom Inc ilet bionic pancreas system
Forest plots of randomised controlled trials that compared continuous glucose monitoring vs. blood glucose monitoring for (A) HbA1c (%), (B) time in range (%), (C) time below range (<3.9 mmol/L) (%), (D) time below range (<3.0 mmol/L) (%), (E) time above range (>10 mmol/L) (%), (F) time above range (>13.9 mmol/L) (%) and (G) coefficient of variability. *, Wada, 2020 data for 1F is % TAR (>13.3 mmol/L). CGM, continuous glucose monitoring; isCGM, intermittently scanned CGM; <t>rtCGM,</t> real‐time <t>CGM;</t> <t>BGM,</t> blood glucose monitoring; HbA1c, glycated haemoglobin; TAR, time above range.
Ilet Bionic Pancreas System, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/7-day+dexcom+g5+sensor/artificial+closed+loop+pancreas+system/pmc12317845-323-22-37
Average 86 stars, based on 1 article reviews
ilet bionic pancreas system - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier
control arm rtcgm  (Dexcom Inc)
86
Dexcom Inc control arm rtcgm
Forest plots of randomised controlled trials that compared continuous glucose monitoring vs. blood glucose monitoring for (A) HbA1c (%), (B) time in range (%), (C) time below range (<3.9 mmol/L) (%), (D) time below range (<3.0 mmol/L) (%), (E) time above range (>10 mmol/L) (%), (F) time above range (>13.9 mmol/L) (%) and (G) coefficient of variability. *, Wada, 2020 data for 1F is % TAR (>13.3 mmol/L). CGM, continuous glucose monitoring; isCGM, intermittently scanned CGM; <t>rtCGM,</t> real‐time <t>CGM;</t> <t>BGM,</t> blood glucose monitoring; HbA1c, glycated haemoglobin; TAR, time above range.
Control Arm Rtcgm, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/7-day+dexcom+g5+sensor/arm+control+rtcgm/pm40757453-87-170-173
Average 86 stars, based on 1 article reviews
control arm rtcgm - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

Image Search Results


Forest plots of randomised controlled trials that compared continuous glucose monitoring vs. blood glucose monitoring for (A) HbA1c (%), (B) time in range (%), (C) time below range (<3.9 mmol/L) (%), (D) time below range (<3.0 mmol/L) (%), (E) time above range (>10 mmol/L) (%), (F) time above range (>13.9 mmol/L) (%) and (G) coefficient of variability. *, Wada, 2020 data for 1F is % TAR (>13.3 mmol/L). CGM, continuous glucose monitoring; isCGM, intermittently scanned CGM; rtCGM, real‐time CGM; BGM, blood glucose monitoring; HbA1c, glycated haemoglobin; TAR, time above range.

Journal: Diabetes, Obesity & Metabolism

Article Title: Continuous glucose monitoring in noninsulin‐treated type 2 diabetes: A critical review of reported trials with an updated systematic review and meta‐analysis of randomised controlled trials

doi: 10.1111/dom.70008

Figure Lengend Snippet: Forest plots of randomised controlled trials that compared continuous glucose monitoring vs. blood glucose monitoring for (A) HbA1c (%), (B) time in range (%), (C) time below range (<3.9 mmol/L) (%), (D) time below range (<3.0 mmol/L) (%), (E) time above range (>10 mmol/L) (%), (F) time above range (>13.9 mmol/L) (%) and (G) coefficient of variability. *, Wada, 2020 data for 1F is % TAR (>13.3 mmol/L). CGM, continuous glucose monitoring; isCGM, intermittently scanned CGM; rtCGM, real‐time CGM; BGM, blood glucose monitoring; HbA1c, glycated haemoglobin; TAR, time above range.

Article Snippet: Cox 2020 USA , T2DM and not using insulin , 30 , 30 (100%) , Periodic rtCGM (Dexcom G5) (four 7‐day periods) plus GEM vs. BGM (usual care) , HbA1c Medication effect score , 3 months , 8.8% , HbA1c: favoured the rtCGM group; −1.30% vs. −0.19% Medication effect score: favoured the rtCGM group; 0.81 vs. −0.02%; p = 0.009.

Techniques: